febuxostat has been researched along with Nephrolithiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Z; Jie, S; Ke, L; Wentao, H; Xiaokang, L; Yunhua, M | 1 |
| Arowojolu, O; Goldfarb, DS | 1 |
1 review(s) available for febuxostat and Nephrolithiasis
| Article | Year |
|---|---|
Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
Topics: Allopurinol; Biomarkers; Calcium Oxalate; Febuxostat; Humans; Indapamide; Kidney; Nephrolithiasis; Risk Factors; Treatment Outcome; Uric Acid; Uricosuric Agents | 2014 |
1 other study(ies) available for febuxostat and Nephrolithiasis
| Article | Year |
|---|---|
Febuxostat Promoted Dissolution of Radiolucent Nephrolithiasis in Patients with Hyperuricemia.
Topics: Adult; Aged; Allopurinol; Febuxostat; Female; Humans; Hyperuricemia; Male; Middle Aged; Nephrolithiasis; Retrospective Studies; Young Adult | 2020 |